Previous Close | 12.36 |
Open | 12.49 |
Bid | 12.33 x 100 |
Ask | 12.54 x 100 |
Day's Range | 12.39 - 12.73 |
52 Week Range | 10.62 - 18.44 |
Volume | |
Avg. Volume | 77,080 |
Market Cap | 418.334M |
Beta (5Y Monthly) | -0.50 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.20 |
Earnings Date | May 10, 2024 - May 14, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 21.00 |
Director Peter Kim of Entrada Therapeutics Inc (NASDAQ:TRDA) has recently increased his stake in the company.
The analysts covering Entrada Therapeutics, Inc. ( NASDAQ:TRDA ) delivered a dose of negativity to shareholders today...
Extended Cash Runway and Progress in Duchenne Muscular Dystrophy Treatments Mark 2023 Milestones